CRISPR

In Chapter 6, author Henry T. Greely describes how news of the birth of gene-edited babies rocked a 2018 summit on human genome editing.

CRISPR and other innovations are likely to open up a wealth of new options for how people have children.

Massive extrachromosomal elements named after the hive-minded cyborg villains in Star Trek may be the first of their kind.

The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.

The masks contain freeze-dried, cell-free biosensors, enabling them to detect pathogens including SARS-CoV-2.

Senators raise concerns about how Eric Lander of the Broad Institute has handled equality issues.

The physiological demands of that long neck get support from a gene involved in strengthening bones and blood vessels, researchers find after inserting the sequence in mice.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.

Researchers combine organoids, CRISPR-Cas9, and cellular barcoding technologies to identify genes that influence brain size.

A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.

Emmanuelle Charpentier and Jennifer Doudna reprogrammed the bacterial immune response into one of the most popular tools for genetics and molecular biology.

Adeno-associated viral vectors can deliver gene therapies, but AAV-neutralizing antibodies might prevent the medicines from working.

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.

Researchers are adapting CRISPR, synthetic biology, and other creative approaches to detect SARS-CoV-2 nucleic acids outside of the lab or doctors’ offices, in the hopes of making diagnostics more affordable and accessible.

An enzyme pulled from toxic bacteria can enter the organelle and perform single-nucleotide DNA swaps.